BEVERLY HILLS, Calif.–(BUSINESS WIRE)–Craig Gordon, MD, Chief Executive Officer of GordonMD® Global Investments LP, announced today that his firm has jointly invested in a private placement financing for Radionetics Oncology. Radionetics Oncology, a clinical stage pharmaceutical company spun out of Crinetics (Nasdaq: CRNX) in 2021, focuses on the discovery and…
Click here to view original post
Copyright © 2023 Biotech Networks, LLC
